Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Marchex (MCHX) Research & Development (2016 - 2025)

Marchex (MCHX) has disclosed Research & Development for 16 consecutive years, with $2.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Research & Development fell 23.7% to $2.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $10.4 million, a 18.42% decrease, with the full-year FY2024 number at $12.4 million, down 19.15% from a year prior.
  • Research & Development was $2.4 million for Q3 2025 at Marchex, down from $2.5 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $5.3 million in Q1 2021 to a low of $2.4 million in Q3 2025.
  • A 5-year average of $3.5 million and a median of $3.2 million in 2024 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: crashed 45.39% in 2021, then soared 36.03% in 2022.
  • Marchex's Research & Development stood at $2.8 million in 2021, then skyrocketed by 36.03% to $3.8 million in 2022, then decreased by 17.89% to $3.2 million in 2023, then dropped by 9.9% to $2.8 million in 2024, then decreased by 16.58% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for MCHX's Research & Development are $2.4 million (Q3 2025), $2.5 million (Q2 2025), and $2.7 million (Q1 2025).